[Leukocytic changes under treatment with L-asparaginase].
D000135:Acid Phosphatase / Q000032:analysis; D000208:Acute Disease; D000251:Adenosine Triphosphatases / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D001215:Asparaginase / Q000494:pharmacology* / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects* / Q000201:enzymology; D001854:Bone Marrow Cells; D002277:Carcinoma / Q000188:drug therapy; D003864:Depression, Chemical; D004950:Esterases / Q000032:analysis; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects* / Q000201:enzymology; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy*; D008206:Lymphatic Diseases / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy*; D010544:Peroxidases / Q000032:analysis; D013268:Stimulation, Chemical
D010544:Peroxidases; D004950:Esterases; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D001215:Asparaginase; D000251:Adenosine Triphosphatases
Leukozytenveränderungen unter Therap;ie mit L-Asparaginase.